F-1MEF 1 d851830df1mef.htm F-1MEF F-1MEF

As filed with the Securities and Exchange Commission on October 24, 2024

Registration No. 333    

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM F-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

WeRide Inc.

(Exact name of Registrant as specified in its charter)

 

 

Not Applicable

(Translation of Registrant’s name into English)

 

 

 

Cayman Islands   7373   Not Applicable

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer

Identification Number)

21st Floor, Tower A, Guanzhou Life Science Innovation Center,

No. 51, Luoxuan Road, Guangzhou International Biotech Island,

Guangzhou 510005

People’s Republic of China

+86 (20) 2909-3388

(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)

 

 

Cogency Global Inc.

122 East 42nd Street, 18th Floor

New York, N.Y. 10168

+1 (800) 221-0102

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

 

Copies to:

 

Haiping Li, Esq.

Skadden, Arps, Slate,

Meagher & Flom LLP

c/o 42/F, Edinburgh Tower,

The Landmark

15 Queen’s Road Central

Hong Kong

+852 3740-4700

 

Yilin Xu, Esq.

Skadden, Arps, Slate,

Meagher & Flom LLP

30/F, China World Office 2

No. 1, Jian Guo Men Wai

Avenue

Beijing

People’s Republic of China

+86 10 6535-5500

 

Brian V. Breheny, Esq.

Skadden, Arps, Slate, Meagher

& Flom LLP and Affiliates

1440 New York Avenue, N.W.

Washington, D.C.

United States

1 202-371-7000

 

Benjamin Su, Esq.

Latham & Watkins LLP

18th Floor,

One Exchange Square

8 Connaught Place

Central, Hong Kong

+852 2912-2500

 

 

Approximate date of commencement of proposed sale to the public: as soon as practicable after the effective date of this registration statement.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☐

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☒ 333-281054

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.

Emerging growth company ☒

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

 

 

The registration statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(b) under the Securities Act of 1933, as amended.

 

 

 


EXPLANATORY NOTE

This Registration Statement is being filed pursuant to Rule 462(b) and General Instruction V to Form F-1, both promulgated under the Securities Act of 1933, as amended. The contents of the Registration Statement on Form F-1 (File No. 333-281054), initially filed by WeRide Inc. (the “Company”) with the Securities and Exchange Commission (the “Commission”) on July 26, 2024, which was declared effective by the Commission on October 24, 2024, including all amendments, supplements and exhibits thereto and each of the documents filed by the Company with the Commission and incorporated or deemed to be incorporated therein, are incorporated herein by reference.

The required opinions and consents are listed on an Exhibit Index attached hereto.

 

2



SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Guangzhou, China, on October 24, 2024.

 

WeRide Inc.
By:  

/s/ Tony Xu Han

  Name:   Tony Xu Han
  Title:   Chairman and Chief Executive Officer

 

4


Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on October 24, 2024.

 

Signature

     

Title

/s/ Tony Xu Han

   

Chairman and Chief Executive Officer

(Principal Executive Officer)

Name: Tony Xu Han  

*

    Director
Name: Yan Li  

*

    Director
Name: Duane Ziping Kuang  

*

    Director
Name: Mohamed Albadrsharif Shaikh Abubaker Alshateri  

*

    Director
Name: Jingzhao Wan  

*

    Director
Name: Takao Asami  

*

    Director
Name: Yibing Xu  

/s/ Jennifer Xuan Li

   

Chief Financial Officer

(Principal Financial and Accounting Officer)

Name: Jennifer Xuan Li  

 

*By:  

/s/ Tony Xu Han

 

Name: Tony Xu Han

Attorney-in-fact

 

5


SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES

Pursuant to the Securities Act of 1933, the undersigned, the duly authorized representative in the United States of WeRide Inc., has signed this registration statement or amendment thereto in New York, New York, United States on October 24, 2024.

 

Authorized U.S. Representative
Cogency Global Inc.
By:  

/s/ Colleen A. De Vries

  Name:   Colleen A. De Vries
  Title:   Senior Vice President

 

6